RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Spotlight Sessions

Home  >  Investor Relations  >  Events & Presentations  >  Spotlight Sessions

Spotlight Sessions

Our QIAGEN Investor Relations Spotlight Sessions are designed to provide insights into our strategic priorities and keep you up to date on the latest developments.

Each Spotlight Session puts the focus on one of our growth priorities while retaining ample time for a live Q&A.

Ep.1 - QIAGEN Spotlight Session QuantiFERON

Explore how QIAGEN is strenghtening the QuantiFERON franchise with a new end-to-end automated workflow developed in collaboration with Inpeco and Diasorin, while expanding testing capabilities through the new chemistry QuantiFERON - TB Gold Plus II. The session includes business updates and a Q&A discussion.

  Full Event  

Learn more about our upcoming engagements and earnings information on the Events & Presentations site.